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Abstract
Background: The speckle tracking echocardiography (STE) method shows the presence of
right ventricular (RV) dysfunction before the advent of RV failure and pulmonary hypertension
in patients with cardiopulmonary disease. We aimed to assess subclinical RV dysfunction in
obstructive sleep apnea (OSA) using the STE method.
Method: Twenty-one healthy individuals and 58 OSA patients were included. According to
severity as determined by the apnea–hypopnea index (AHI), OSA patients were examined in
three groups: mild, moderate and severe. RV free wall was used in STE examination.
Results: Right ventricle strain (ST %) and systolic strain rate (STR-S 1/s) were decreasing
along with the disease severity (ST — healthy: –34.05 ± –4.29; mild: –31.4 ± –5.37; modera-
te: –22.75 ± –4.89; severe: –20.89 ± –5.59; p < 0.003; STR-S — healthy: –2.93 ± –0.64;
mild: –2.85 ± –0.73; moderate: –2.06 ± –0.43; severe: –1.43 ± –0.33; p < 0.03). Correlated
with the disease severity, the RV early diastolic strain rate (STR-E) was decreasing and the
late diastolic strain rate was increasing (STR-E — healthy: 2.38 ± 0.63; mild: 2.32 ± 0.84;
moderate: 1.66 ± 0.55; severe: 1 ± 0.54; p < 0.003; STR-A — healthy: 2.25 ± 0.33; mild:
2.32 ± 0.54; moderate: 2.79 ± 0.66; severe: 3.29 ± 0.54; p < 0.03). The STR-E/A ratio was
found to be in a decreasing trend along with the disease severity (healthy: 1.08 ± 0.34; mild:
1.06 ± 0.46; moderate: 0.62 ± 0.22; severe: 0.34 ± 0.23; p < 0.03).
Conclusions: Subclinical RV dysfunction can be established in OSA patients even in the
absence of pulmonary hypertension and pathologies which could have adverse effects on RV
functions. In addition to the methods of conventional, Doppler and tissue Doppler echo-
cardiography, using the STE method can determine RV dysfunction in the subclinical phase.
(Cardiol J 2012; 19, 2: 130–139)
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Introduction
Previous studies have shown the adverse ef-
fects of obstructive sleep apnea (OSA) on myocar-
dial functions [1]. Right ventricle (RV) function
plays a crucial role in the morbidity and mortality
of patients with cardiopulmonary disease. Early de-
termination of RV dysfunction before pulmonary ar-
terial hypertension (PAH) development is impor-
tant in preventing progression to heart failure and
even death [2].
Global RV functions are usually assessed by
means of RV fractional area change (FAC) and tri-
cuspid annular plane systolic excursion (TAPSE);
however, both techniques have intrinsic limitations
[3]. A conventional two-dimensional (2D) echocar-
diography does not allow a comprehensive evalua-
tion, because the RV has a complex crescent shape
and is wrapped around the left ventricle (LV). The
tissue Doppler echocardiography method is more
sensitive than the 2D echocardiography method for
determining  subclinical cardiac dysfunction, but it
is influenced by the cardiac translational motion and
tethering of adjacent myocardial tissue and it has
high inter-observational variability [4, 5].
The 2D speckle tracking echocardiography
(2D-STE) method assesses myocardial deforma-
tion and the myocardial deformation rate by track-
ing speckles in the myocardium on grayscale
(B-mode) images. It can be used to evaluate both
global and regional myocardial strain (ST %) and
the strain rate (STR 1/s) without the limitation of
a Doppler beam angle. In previous studies using
the 2D-STE method, the coexistent RV dysfunc-
tion has been determined in patients with congeni-
tal heart diseases, systemic sclerosis, pulmonary
hypertension, systemic hypertension, diabetes
mellitus and pulmonary thromboembolism. Be-
sides these, results of these studies were found
to be correlated well with the TAPSE, FAC, myo-
cardial performance index (MPI), and isovolumic
acceleration (IVA) parameters [6].
The assessment of radial functions in the
parasternal view is difficult because of the anterior
location of the RV leading to significant artifacts.
The circumferential functions of the RV are not
usually assessed. For these reasons, in the evalua-
tion of RV functions, only the longitudinal ST and
STR parameters are used. It is debatable whether
the interventricular septum should be included as
a part of the assessment of global RV function with
the 2D-STE method. The interventricular septum
is influenced more by the LV than the RV, with the
exception of the advanced RV dysfunction. There-
fore, the RV free wall in the apical four-chamber
view is used for ST and STR assessment [5, 7].
In our study, we aimed to investigate the rela-
tionship between the subclinical RV dysfunction and
disease severity in OSA patients without pulmonary
hypertension and LV dysfunction with standard and
tissue Doppler echocardiography and 2D-STE
methods.
Methods
Determination of patient and control groups
Patients between the ages of 30 and 60 with
an OSA diagnosis who were examined at the Akde-
niz University, Faculty of Medicine, Chest Diseases
Polyclinic between March 2009 and October 2010
were included in this study after conducting poly-
somnographies at the sleep laboratory. To create
a control group, we chose healthy individuals be-
tween the ages of 30 and 60 with no cardiovascular
diseases who came to the Akdeniz University, Fa-
culty of Medicine, Cardiology outpatient clinic for
various reasons. The healthy group used in the
study included patients suitable for the study from
the perspective of cardiac structure and functions,
those with no night snoring or day-time sleepiness,
who scored less than 10 on the Epworth Sleepiness
Scale, and had low risk of OSA in the Berlin survey
form evaluation [8, 9].
Exclusion criteria were as follows: angina and
angina equivalent symptoms, abnormal electrocar-
diography, abnormal cardiovascular stress test and
abnormal myocardial scintigraphy, an LV ejection
fraction (LVEF) lower than 50%, mean pulmonary
artery pressure (MPAP) > 25 mm Hg, a moderate
or severe degree of valvular stenosis or insufficien-
cy, a documented history of coronary and periphe-
ral vascular diseases, diabetes mellitus, hypothy-
roidism and hyperthyroidism, renal failure, hepatic
failure, restrictive and obstructive pulmonary dis-
ease, connective tissue disorders, atrial fibrillation,
pacemaker, congenital cardiac disease, pericardial
disease, and smoking. In the physical examination,
patients with a systolic blood pressure value of
> 140 mm Hg and diastolic blood pressure value of
> 90 mm Hg after averaging three separate blood
pressure measurements taken at ten minute inter-
vals, as well as patients receiving antihypertensive
treatment, were accepted as hypertensive. Also,
patients who were receiving OSA treatment were
excluded. Informed consent was given by everyone
included in the study, which was approved by the
local ethical committee of Akdeniz University Medi-
cal School.
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All individuals’ blood pressures, pulse rates and
anthropometric measures were recorded before
echocardiographic examination. Body mass index
(BMI) and body surface areas (BSA) were derived
from the anthropometric measures.
Polysomnography
Polysomnography was performed with 16 chan-
nels Embla (Medcare Inc, Iceland) with continuous
monitoring from a sleep technician. The system
consists of four channels of electroencephalography,
two channels of electrooculography, submental
electromyography, oronasal air flow, thoracic and
abdominal movements, pulse oximeter oxygen sa-
turation, tibial electromyography, body position de-
tector, electrocardiogram, and tracheal sound.
Apnea was defined as complete stopping of air-
flow lasting more than 10 s. Hypopnea was defined
as 30% or more reduction in respiratory airflow last-
ing more than 10 s and accompanied by a decrease
of more than 4% in oxygen saturation. The aver-
age number of episodes of apnea and hypopnea per
hour of sleep was defined as the apnea–hypopnea
index (AHI). According to the severity, included pa-
tients were classified as having mild OSA (AHI 5–
–15), moderate OSA (AHI 16–30); or severe OSA
(AHI > 30). Sleep stages were scored following the
standard criteria with 30-s epochs and were reviewed
and verified by a certified sleep physician [10].
Echocardiography
Echocardiography was performed in the left late-
ral decubitus position with an ultrasound machine
GE-Vingmed Vivid 7 system (GE-Vingmed Ultra-
sound AS, Horten, Norway) and 3S-RS (3.5 MHz)
probe. Averages of three consecutive cycles were
measured for all echocardiographic data. Images
were obtained from parasternal and apical positions
using 2D, M-mode and Doppler echocardiographic
techniques. Examinations were performed by two
experienced cardiologists who were unaware of the
disease presence and severity of the individuals.
The LV end-diastolic and end-systolic dimensions,
interventricular septum and posterior wall thick-
ness were measured with M-mode echocardio-
graphy. LV mass was determined by the Devereux
formula, and the LV mass index (LVMI) was derived
by dividing the LV mass by the BSA [11]. LVEF was
measured using the biplane Simpson’s method. LV
inflow velocity was recorded from the pulse wave
Doppler sample volume placed proximal to mitral
leaflet tips in the apical four-chamber view. Early
diastolic peak flow velocity (E), and late diastolic
peak flow velocity (A) were recorded, and the E/A
ratio and the deceleration time (DecT) of E wave
were calculated [3].
RV global systolic function was assessed as the
TAPSE by the 2D difference of the end-diastolic and
end-systolic lines traced between the center of the
ultrasound fan origin and the junction of the RV lat-
eral tricuspid annulus in the apical four-chamber
view. Right atrium volume (RAV) was calculated by
the area-length method in apical four-chamber view
and the right atrial volume indices (RAVI) were
derived by dividing the RAV by the BSA. Tricuspid
inflow velocities were obtained with pulsed wave
Doppler recording in the apical four-chamber view,
by placing the sample volume at the tips of the tri-
cuspid valve leaflets. The peak early diastolic (E)
and late diastolic (A) tricuspid inflow velocities and
the DecT were measured. Right ventricular outflow
tract acceleration time (RVAT) was calculated as
the time interval between the onset of systolic ve-
locity and peak systolic velocity. The mean pulmo-
nary artery (PA) pressure (MPAP) was calculated
with the Mahan formula [90 – (0.62 × RVAT)]. The
systolic PA pressure (SPAP) was estimated from
the sum of the estimated right atrial (RA) pressure
and the pressure gradient between RA and RV,
which is calculated using the tricuspid regurgitant
peak velocity [12].
Tissue Doppler imaging (TDI) was recorded
from the apical four-chamber view with the pulse-
wave Doppler sample volume placed on the septal
mitral annulus and the tricuspid lateral annulus.
Peak systolic (S) velocity, peak early (E’) and peak
late (A’) diastolic myocardial annular velocity, iso-
volumic relaxation time (IVRT), and isovolumic
contraction time (IVCT) were measured. The ratio
between the early diastolic mitral flow (E) and ear-
ly diastolic myocardial velocity (E’) was calculated
(E/E’). Myocardial performance index (MPI) was
calculated with the Tei index formula for both ven-
tricles. Isovolumic acceleration (IVA) for the RV
was calculated by dividing the isovolumic contrac-
tion peak velocity by the time interval between the
onset of this wave and its peak velocity [3, 12].
2D-STE analysis was performed with a soft-
ware package (Echopac PC, version 8.0, GE Health-
care) from the apical view. Standard grayscale 2D
images were obtained at a frame rate of 70–90 fra-
me/s. The RV free wall endocardial border was
traced manually from an end-systolic frame. Then,
the epicardial border was automatically detected by
the software and the region of interest (ROI) was
manually adjusted to include the entire myocardial
wall. The quality tracking was verified and the ROI
was modified, and corrected by the observer if nec-
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essary to obtain optimal tracking. The apical four-
-chamber images of the RV free wall were processed
by the software. Strain (RV-ST), systolic strain rate S
(RV-STR-S), early diastolic strain rate (RV-STR-E),
and late diastolic strain rate (RV-STR-A) curves
were obtained. The early and late diastolic strain
rate ratio (RV-STR-E/RV-STR-A) was calculated.
The ST-STR graphic result of 2D-STE analysis of
RV free wall, and the ST, STR-S, STR-E and STR-A
values on this graphic are presented in Figure 1.
Statistical analysis
The study data was analyzed with SPSS v. 18.0
for Windows. Numeric variables were presented as
mean ± standard derivation or median (minimum–
–maximum), and categorical variables as rates. Three
or more group comparisons were performed by one-
-way ANOVA for normally distributed variables and
by the Kruskal-Wallis test for ordinal variables or
continuous variables not distributing normally. The
Tukey test was used for post-hoc analysis after per-
forming ANOVA. The Mann-Whitney U test with
Bonferroni correction was used for post-hoc analy-
sis after performing the Kruskal-Wallis test. The
alpha critical value for the Mann-Whitney U test in
Bonferroni correction was accepted as 0.03 because
the Mann-Whitney U test loses its value below 0.03.
The normality analysis was performed by the Kol-
mogorov-Smirnov test. The Pearson correlation
test was used in order to assess the relation be-
tween the severity and presence of OSA with all of
the echocardiographic (standard tissue Doppler and
speckle tracking imaging) variables. All the hypo-
theses were constructed as two-tailed, and an alpha
critical value of 0.05 was accepted as significant.
Inter- and intra-observer variability
Intra-observer variability was determined by
the observer repeating the measurement of the glo-
bal longitudinal ST and STR in 20 random OSA pa-
tients or control subjects two weeks after the first
measurement. Inter-observer variability was dete-
rmined by another observer measuring these va-
riables in the same database. The Blant-Alman
analysis method was used to determine inter- and
intraobserver variability.
Results
In our study, 79 individuals, consisting of
21 healthy individuals, 20 mild OSA patients, 19 mode-
rate OSA patients, and 19 severe OSA patients,
were included. The BMI values of OSA groups were
found to be higher than the healthy group; howev-
Figure 1. ST-STR graphic result of 2D-STE analysis of RV free wall, and ST, STR-S, STR-E and STR-A values.
Comparative display of RV-ST, RV-STR-S, RV-STR-E, and RV-STR-A parameters in a healthy individual (A) and in an
obstructive sleep apnea patient. Left panel. Global RV-ST curves; Right panel. Global RV-STR curves. Obstructive
sleep apnea patient (B) has lower RV-ST, RV-STR-S and RV-STR-E and higher RV-STR-A compared to healthy
individual (A).
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er, no differences were observed between OSA
groups. Detailed demographic, clinical variables and
AHI levels of the groups are presented in Table 1.
Echocardiographic data belonging to LV and
results of comparisons made between data of groups
are presented in Table 2. While the LV wall thick-
ness of individuals with OSA was observed to be
higher than those in the healthy group, there were
no LVMI differences between groups. The left atrial
volume index, DecT, and IVRT values of the OSA
group were found to be higher than the healthy
group. The E/A value was found to be lower in the
mild OSA group than the healthy group; however,
no differences between other groups were ob-
served. While the MPI and E/E’ values were cor-
related with the disease severity, differences in
values were observed among groups especially from
the moderate OSA group onward.
The echocardiographic data belonging to RV
and RA and the results of comparison made between
data of groups are presented in Table 3. No differ-
ences were observed between groups in terms of
A, S velocities and PAP. It was observed that RAVI,
DecT, A’ velocity, E/ E’ ratio and MPI values pro-
portionally increased along with the disease sever-
ity. Furthermore, the difference was more notice-
able in moderate and severe OSA groups. TAPSE,
E velocity, E/A ratio, E’ velocity and IVA values of
Table 2. Standard two-dimensional, Doppler and tissue Doppler left ventricular echocardiographic
parameters of the patients and the control group.
Healthy Mild OSA Moderate OSA Severe OSA
EF [%] 64.24 ± 3.75 64.25 ± 3.76 63.68 ± 5.37 63.21 ± 3.17
DVI [mL/m2] 37.38 ± 9.22 37.34 ± 10.34 36.78 ± 7.76 33.9 ± 9.64
SVI [mL/m2] 13.44 ± 3.38 13.22 ± 3.67 13.42 ± 3.45 13.32 ± 4.77
IVSD [cm] 0.89 ± 0.9 1.03 ± 0.1† 1.03 ± 0.13† 1.13 ± 0.13†
PWD [cm] 0.88 ± 0.07 1.03 ± 0.09† 1.04 ± 0.12† 1.11 ± 0.13†
LVMI [g/m2] 86.46 ± 18.74 93.25 ± 16.63 94.50 ± 22.87 103.51 ± 22.89
LAVI [mL/m2] 21.63 ± 4.65 22.15 ± 4.75 27.44 ± 6.99† 32.31 ± 5.11†,‡
E/A 1.19 ± 0.24 0.96 ± 0.16† 1.01 ± 0.3 1.11 ± 0.28
DecT [ms] 163 ± 26.2 227.35 ± 31.1† 216.35 ± 60.41† 199.36 ± 39.5†
IVRT [ms] 88.29 ± 12.49 106.3 ± 12.83† 108.84 ± 12.91† 113.26 ± 10.42†
MPI 0.46 ± 0.08 0.48 ± 0.08 0.55 ± 0.06† 0.6 ±  0.13†,‡
E/E’ 8.13 ± 2.22 8.62 ± 2.68 11.31 ±  2.87†,‡ 13.89 ± 2.32†,‡,*
†p < 0.03 compared to healthy individuals; ‡p < 0.03 compared to mild OSA patients; *p < 0.03 compared to moderate OSA patients; DecT — dece-
leration time; DVI — diastolic volume index; E/A — ratio between diastolic early (E) and late diastolic mitral inflow (A) velocities; E/E’ — ratio between
early diastolic mitral inflow velocity and early diastolic annular velocity; EF — ejection fraction; IVRT — isovolumic relaxation time; IVSD — interven-
tricular septum diastolic thickness diameter; LAVI — left atrial volume index; LVMI — left ventricular mass index; MPI — myocardial performance
index; OSA — obstructive sleep apnea; SVI — systolic volume index; PWD — posterior wall diastolic thickness diameter
Table 1. Clinical, demographic characteristics and AHI levels of the patients.
Healthy Mild OSA Moderate OSA Severe OSA
(n = 21) (n = 20) (n = 19) (n = 19)
Age [years] 45.38 ± 4.5 46.95 ± 6.4 46.79 ± 5 46.68 ± 7.6
Female 11 (52.4%) 5 (25%) 5 (26.3%) 3 (15.8%)
Male 10 (47.6%) 15 (75%) 14 (73.7%) 16 (84.2%)
BMI [kg/m2] 26.35 ± 4.14 28.68 ± 3.44 29.05 ± 2.26 29.80 ± 2.38†
BSA [m2] 1.84 ± 0.16 1.97 ± 0.17 2 ± 0.18 2.01 ± 0.14
SBP [mm Hg] 120.95 ± 10.56 118.75 ± 6.04 120.26 ± 6.76 121.05 ± 8.09
DBP [mm Hg] 75.48 ± 6.69 76 ± 6.19 73.68 ± 5.97 75.79 ± 5.07
Pulse [bpm] 74.33 ± 10.89 76 ± 7.15 77.21 ± 5.52 78.21 ± 6.24
AHI [per hour] N/A 10.73 ± 2.57 20.52 ± 2.60‡ 58.1 ± 16.27‡,*
†p < 0.03 compared to healthy individuals; ‡p < 0.03 compared to mild OSA patients; *p < 0.03 compared to moderate OSA patients; AHI — apnea–
–hypopnea index; BMI — body mass index; BSA — body surface area; OSA — obstructive sleep apnea; SBP — systolic blood pressure; DBP — dia-
stolic blood pressure
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moderate and severe OSA groups were noted to be
lower than healthy and mild OSA groups.
The ST and STR parameters of the RV free wall
are summarized in Table 4. RV-ST and RV-STR-S
values were observed to be lower in the moderate
and severe OSA groups than in the healthy and mild
OSA groups. While no differences were observed
between moderate and severe OSA groups in terms
of RV-ST values, the RV-STR-S value of the severe
OSA group was lower than the moderate OSA
group. While the RV-STR-E value began to de-
crease starting from the moderate OSA group along
with the disease severity, the RV-STR-A value was
observed to be increasing. The RV-STR-E/A value
began to decrease along with the disease severity,
starting from the moderate OSA group, with stati-
stical significance.
The relationship between AHI and LV MPI
with RV functions was evaluated in a correlation
analysis. There was nocorrelation found between
the AHI and E/A value and S velocity value. A rela-
tionship between LV-MPI with RAVI and E/A valu-
es was not found. The 2D-STE parameters corre-
lated better with AHI than the other echocardio-
graphic parameters. A lower degree of correlation
was observed between LV-MPI values and RV func-
tions. The correlation analysis was repeated after
performing BMI adjustment and it was observed
that the relationship between AHI and LV-MPI with
RV functions still remained. The results of the cor-
relation analysis are given in Table 5. The relation-
ship between AHI and RV-ST, and RV-STR-E/A are
summarized in Figure 2.
Intra- and inter-observer variables
Twenty patients were randomly selected for
the assessment of intra- and interobserver variables
in measurements of RV-ST, RV-STR-S, RV-STR-E,
Table 3. Standard two-dimensional, Doppler and tissue Doppler right ventricular echocardiographic
parameters of the patients and the control group.
Healthy Mild OSA Moderate OSA Severe OSA
RAVI [mL/m2] 15.56 ± 4.94 17.31 ± 6.24 21.89 ± 7.91 28.85 ± 7.97†,‡
TAPSE [mm] 24.76 ± 1.55 22.30 ±  2.39 21.11 ± 1.56† 19.42 ± 1.64†,‡,*
E [m/s] 0.75 ± 0.11 0.73 ± 0.01 0.64 ± 0.13† 0.57 ± 0.09†,‡
A [m/s] 0.48 ± 0.09 0.46 ± 0.09 0.46 ± 0.07 0.49 ± 0.09
E/A ratio 1.62 ± 0.23 1.44 ± 0.24 1.42 ± 0.22 1.37 ± 0.19†
DecT [ms] 162.33 ± 43.89 194.25 ± 44.95 206.37 ± 46.32 242.26 ± 54.63†
S [m/s] 0.17 ± 0.03 0.16 ± 0.03 0.15 ± 0.02 0.14 ± 0.02
E’ [m/s] 0.16 ± 0.03 0.14 ± 0.03 0.13 ± 0.03† 0.11 ± 0.03†
A’ [m/s] 0.15 ± 0.02 0.16 ± 0.01 0.18 ± 0.05 0.19 ± 0.03†,‡
E/E’ ratio 4.19 ± 1.22 4.37 ± 1.22 5.77 ± 1.27†,‡ 7.12 ± 2.29†,‡
MPI 0.43 ± 0.09 0.46 ± 0.09 0.53 ± 0.08† 0.56 ±  0.11†,‡
IVA [m/s2] 4.51 ± 0.65  4.38 ± 1.51 3.5 ± 0.98† 2.52 ± 1.1†,‡
SPAP [mm Hg] 25.61 ± 5.43 27.62 ± 4.32 29.78 ± 4.24 32.06 ± 3.71
MPAP [mm Hg] 19.91 ± 2.78 18.12 ± 5.39 17.73 ± 4.7 18.74 ±  4.36
†p < 0.03 compared to healthy individuals; ‡p < 0.03 compared to mild OSA patients; *p < 0.03 compared to moderate OSA patients; A — tricuspid
valve late diastolic velocity; A’ — tricuspid anulus late diastolic myocardial velocity; DecT — deceleration time; E  — tricuspid valve early diastolic
velocity; E’ — tricuspid annulus early diastolic myocardial velocity; IVA — myocardial acceleration during isovolumic contraction; MPAP — mean
pulmonary artery pressure; MPI — myocardial performance index; OSA — obstructive sleep apnea; RAVI — right atrium volume index; SPAP —
systolic pulmonary artery pressure; S’ — tricuspid annulus systolic myocardial velocity; TAPSE — tricuspid annular plane systolic excursion
Table 4. Right ventricle ST and STR parameters of the patients and the control group.
Healthy Mild OSA Moderate OSA Severe OSA
RV-ST [%] –34.05 ± –4.29 –31.4 ± –5.37 –22.75 ± –4.89†,‡ –20.89 ± –5.59†,‡
RV-STR-S [1/s] –2.93 ± –0.64 –2.85 ± –0.73 –2.06 ± –0.43†,‡ –1.43 ± –0.33†,‡,*
RV-STR-E [1/s] 2.38 ± 0.63 2.32 ± 0.84 1.66 ± 0.55† 1 ± 0.54†,‡
RV-STR-A [1/s] 2.25 ± 0.33 2.32 ± 0.54 2.79 ± 0.66† 3.29 ± 0.54†,‡
RV-STR-E/A ratio 1.08 ± 0.34 1.06 ± 0.46 0.62 ± 0.22†,‡ 0.34 ± 0.23†,‡,*
†p < 0.03 compared to healthy individuals; ‡p < 0.03 compared to mild OSA patients; *p < 0.03 compared to moderate OSA patients; OSA — obstructive
sleep apnea; RV — right ventricle; ST — strain; STR-S — systolic strain rate; STR-E — early diastolic strain rate; STR-A — late diastolic strain rate
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and RV-STR-A. The mean difference for interobserv-
er agreement for RV-ST was 0.32 (95% confidence
interval [CI] and –0.8 to 0.85). The mean difference
for intraobserver agreement for RV-ST was 0.56
(95% CI –0.44 to 1.04). The mean differences for
interobserver agreement for RV-STR were 0.78
(95% CI 0.52 to 0.85), –0.69 (95% CI –0.88 to –0.52),
–0.7 (95% CI –0.86 to –0.53) for RV-STR-S, RV-STR-E,
and RV-STR-A, respectively. The mean differen-
ces for intraobserver agreement for RV-STR were
0.81 (95% CI 0.51 to 0.84), –0.69 (95% CI –0.86 to
–0.52), –0.46 (95% CI –0.68 to –0.24) for RV-STR-S,
RV-STR-E, and RV-STR-A, respectively.
Discussion
OSA is characterized by repeated episodes of
upper respiratory tract obstruction during sleep and
arterial oxygen desaturation. OSA is often associated
with certain cardiovascular risk factors such as hyper-
tension, diabetes, and obesity. Repeated episodes of
hypoxia, hypercapnia and changes in intrathoracic
pressure may trigger pathophysiological mechanisms
such as sympathetic hyperactivity, oxidative stress,
systemic inflammation, hypercoagulability and endo-
thelial dysfunction. Those pathophysiologic changes
may have a direct or an indirect negative effect on
myocardial structure and functions [13].
In our study, we observed that ST and STR-S
values that display the systolic functions of the RV
decrease correlated with disease severity. We ob-
served that the RV systolic dysfunction was start-
ing from the moderate OSA group onward. In terms
of diastolic function parameters, we observed that
the STR-E and STR-E/A values were decreased
along with disease severity. But the STR-A value
was found to be increased along with disease se-
verity. The AHI correlated with RV functions bet-
ter than the LV-MPI. There was a stronger rela-
tionship between AHI and 2D-STE parameters
compared to other echocardiographic parameters.
The relationship between the degree of RV dysfunc-
tion and OSA was found to be independent of BMI.
Table 5. Correlation of the AHI and the left
ventricular MPI ratio with the echocardiographic
right ventricular parameters.
AHI LV-MPI
r p r p
TAPSE –0.520 < 0.001 –0.488 < 0.001
TR-S’ –0.326 0.013 –0.265 0.018
MPI 0.342 0.009 0.340 0.002
IVA –0.415 0.001 –0.410 < 0.001
RAVI 0.467 < 0.001 0.198 0.08
E/A 0.480 0.095 0.339 0.11
E/E’ 0.573 < 0.001 0.273 0.015
RV-ST [%] –0.694 < 0.001 0.379 0.001
RV-STR-S [1/s] –0.710 < 0.001 –0.356 < 0.001
RV-STR-E/A –0.704 < 0.001 –0.329 0.003
AHI — apnea-hypopnea index; E/A — ratio of tricuspid valve early
and late diastolic myocardial velocity; E/E’ — ratio of tricuspid valve
early diastolic velocity and tricuspid annulus early myocardial velocity;
IVA — myocardial acceleration during isovolumic contraction; LV —
left ventricle; MPI — myocardial performance index; RAVI — right
atrium volume index; RV — right ventricle; RV-ST — right ventricle
strain; RV-STR- E/A — ratio of right ventricle early diastolic and late
diastolic strain rate; RV-STR-S — right ventricle systolic strain rate;
S’ — tricuspid annulus systolic myocardial velocity; TAPSE — tricuspid
annular plane systolic excursion
Figure 2. Relationship between AHI and RV-STR-E/A ratio (A), RV-ST (B); AHI — apnea-hypopnea index;
RV-ST — right ventricular strain; RV-STR-E/A — ratio of right ventricular early and late diastolic strain rates.
A B
137
Refik Emre Altekin et al., Right ventricular function assessment with STE in OSA
www.cardiologyjournal.org
While the cause of RV dysfunction in OSA was
not certain, repetitive nocturnal arterial oxygen
desaturation and hypercapnia, large intrathoracic
negative pressure swings and acute increases in
PAP may be the responsible mechanisms [14]. Ex-
perimental intermittent hypoxia administered for
part of the day for just a few weeks results in pul-
monary artery remodeling and RV hypertrophy in
rodents [15]. Pulmonary vasoconstriction that aris-
es in the hypoxic and hypercapnic stages, as well
as endothelium dysfunction in the pulmonary vas-
cular bed caused by oxidative stress triggered by
OSA, are responsible for the development of pul-
monary remodeling in OSA patients. Endothelial
nitric oxide synthesis in the pulmonary bed is ad-
versely affected by endothelium dysfunction in OSA
[16]. The generation of negative intrathoracic pres-
sure against an occluded airway is the unique fea-
ture of OSA which causes increased venous return,
volume overload and distension of the RV during
apnea periods. In OSA, the LV dysfunction may lead
to RV dysfunction. RV functions are often influ-
enced in LV pathologies as a result of direct injury
extension, afterload, changes, or ventricular interde-
pendence, which is mainly due to the close anatom-
ical association between the two ventricles [17, 18].
Myocardial oxygen demands may be increased be-
cause of structural changes in RV. Insufficient sup-
ply of this increased demand may cause RV is-
chemia and dysfunction [13].
Chronic obstructive pulmonary disease, mor-
bid obesity and LV failure may accompany OSA dis-
ease. Pulmonary hypertension and RV failure are
commonly seen in these cases. However, in stud-
ies that have examined OSA patients without addi-
tional diseases which could have adverse effects on
RV functions, a moderate degree of pulmonary hy-
pertension (MPAP: 20–30 mm Hg) has been ob-
served in 20–40% of cases, and a correlation be-
tween PAP levels and RV functions was noted. Also,
in asymptomatic OSA patients, increases in PAP
with exercise and decreases in their functional ca-
pacity were observed [14]. Therefore, the evalua-
tion of RV functions in OSA patients is necessary
for prognosis of the disease.
In our study, RV functions were first evaluat-
ed with 2D and Doppler echocardiography. While
the TAPSE value decreased with the severity of the
disease, and was found to be especially low in the
severe OSA group compared to other groups,
a moderate correlation was observed between the
TAPSE value and AHI. In our study, the tricuspid
E velocities decreased from the moderate OSA
group and the tricuspid E/A ratios decreased from
the severe OSA group onward, but no differences
were observed between the tricuspid A velocities
of groups. Also, no correlation was found between
the AHI and Tri E/A ratios. The RV 2D echocar-
diographic and Doppler echocardiographic param-
eters displayed the shortcomings of these methods
in the determination of early stage RV dysfunction.
Because of the shortcomings of the convention-
al echocardiography and pulse Doppler examina-
tions, the relationship between OSA and RV func-
tions have been examined using the tissue Doppler
method in recent years. Besides the systolic and
diastolic parameters determined by the tissue Dop-
pler method, in various studies the RV MPI and IVA
parameters were used to evaluate global RV func-
tions in OSA patients [4, 19, 20]. While no differ-
ences were observed between groups in S wave
velocity from tissue Doppler parameters, the IVA
value decreased from the moderate OSA group on-
ward, related to the severity of the disease. The
related result proved that the IVA value non-related
to volume load was more sensitive than S waves in
determining subclinical cardiac damage [21, 22].
Tricuspid E/E’ values were found to be increased
along with the severity of OSA. In a previous study,
observation of the correlation between the E/E’ va-
lue and the invasively measured RA pressure
showed that there is a correlation between the in-
creasing RV filling pressure and the related param-
eter [23]. In OSA patients, the increased E/E’ val-
ue indicates the presence of increased RV filling
pressure and subclinical myocardial dysfunction.
The new echocardiographic method of speck-
le tracking assesses myocardial strain and strain
rate by tracking speckles in the myocardium on
gray-scale (B-mode images) and can be used to
evaluate both global and regional myocardial strain
without being limited by Doppler beam angle, teth-
ering effect and load dependency [24]. In a study
which compared the healthy individuals and patients
with RV dysfunction, the ST and STR values were
found to be decreased proportionally to the RV dys-
function severity, and these values were found to
be related to systolic function parameters such as
TAPSE and RV FAC. While there are differences
between groups in the RV global ST and STR va-
lues, there was no difference among groups in terms
of RV segments. A high degree of inter- and intra-
-observer compatibility in the study indicates the
reliability of the 2D-STE values used in the evalu-
ation of RV functions [25].
In our study, ST and STR-S values related to
RV systolic functions were found to be decreased
along with the severity of the disease. While the
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ST values were not different among severe and mo-
derate OSA patients, the STR-S value of severe OSA
patients were found to be lower than that of the
moderate OSA patients. This could be the result of
a previously affected STR-S parameter in RV sys-
tolic dysfunction caused by OSA. Similar findings
were observed in the study conducted by Tugcu et al.
[26]. The RV free wall basal and mid segment systolic
ST and STR values were calculated with the 2D-ST
method and the results were compared between
healthy individuals and OSA patients without pul-
monary hypertension. The ST and STR-S values of
both segments were found to be lower in OSA pa-
tients compared to the control group.
In our study, besides the systolic functions of
RV, we also assessed the diastolic RV functions
with the 2D-STE method. While the STR-E and
STR-E/STR-A values were found to be decreased
along with the disease severity, the STR-A values
were found to be increased. These results indicat-
ed that RV systolic and diastolic longitudinal func-
tions in OSA were corrupted from the moderate
OSA group onwards.
The stronger correlation of RV strain and strain
rate parameters with the AHI suggests to us that
the RV dysfunction can be determined using the 2D-
-STE method in the subclinical phase. In our study,
the presence of a weaker correlation between LV-
-MPI and RV functions supports the hypothesis that
the direct effect of OSA has a potent impact on RV
functions.
Limitations of the study
The first limitation of our study is the use of
the Epworth and Berlin scales rather than the AHI
in the selection of control individuals. However, in
daily clinical practice, we use those methods for the
selection of appropriate patients for the polysom-
nography test. In addition, previous reports have
demonstrated the correlation of the Epworth Sleep-
iness Scale with the AHI [27].
Secondly, our study population was relatively
small, and finally, the RV dimensions and wall thick-
ness were not measured because conventional
echocardiography calculations of these variables are
difficult due to the atypical and abnormal shape of
the RV. The RV functions were corroborated by an
independent method, such as magnetic resonance
imaging or radionuclide ventriculography, which
may limit the ability to detect and quantify signifi-
cant associations between OSA severity and the
degree of RV dysfunction. Despite the subjects
excluded with diseases which have adverse effects
on myocardial function, such as diabetes, coronary
artery disease and hypertension, the BMI of OSA
patients was found to be higher than that of normal
healthy individuals. This difference may have an
effect on the results of our study; however, even
after adjustment of the BMI, the RV mechanical
parameters were still correlated with the OSA pres-
ence and severity. This showed us that our study
findings were not affected by the BMI.
Conclusions
In OSA patients, before the development of RV
failure and pulmonary hypertension, it is important
to detect subtle RV dysfunction for the prevention
of cardiac complications. Even in the absence of
pathologies which could have adverse effects on RV
functions, OSA itself may lead to RV dysfunction.
Besides the direct effect of OSA on RV myocardial
functions, the accompanying LV dysfunction may
have additional effects on RV dysfunction via inter-
ventricular interactions. In addition to conventio-
nal and Doppler echocardiographic methods, with the
2D-STE method, the RV functions can be assessed
in detail and subtle RV dysfunction can be detect-
ed. Additional studies using the 2D-STE method are
necessary to determine the ST and STR values for
the diagnosis of RV dysfunction. In addition, pro-
spective studies using the 2D-STE method are
needed to demonstrate the impact of RV functions
on the prognosis of OSA.
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